nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Hyperamylasaemia—Cyclosporine—focal segmental glomerulosclerosis	0.142	0.251	CcSEcCtD
Abacavir—ADH6—nephron tubule—focal segmental glomerulosclerosis	0.122	0.28	CbGeAlD
Abacavir—ADH6—kidney—focal segmental glomerulosclerosis	0.107	0.246	CbGeAlD
Abacavir—ADH6—cortex of kidney—focal segmental glomerulosclerosis	0.104	0.24	CbGeAlD
Abacavir—Breath sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0446	0.0788	CcSEcCtD
Abacavir—Acute respiratory distress syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0328	0.0579	CcSEcCtD
Abacavir—ADK—nephron tubule—focal segmental glomerulosclerosis	0.0282	0.0649	CbGeAlD
Abacavir—ADK—kidney—focal segmental glomerulosclerosis	0.0248	0.0571	CbGeAlD
Abacavir—UGT1A1—kidney—focal segmental glomerulosclerosis	0.0244	0.0563	CbGeAlD
Abacavir—ADK—cortex of kidney—focal segmental glomerulosclerosis	0.0241	0.0556	CbGeAlD
Abacavir—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0149	0.0263	CcSEcCtD
Abacavir—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0145	0.0257	CcSEcCtD
Abacavir—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0231	CcSEcCtD
Abacavir—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0215	CcSEcCtD
Abacavir—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00967	0.0171	CcSEcCtD
Abacavir—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00898	0.0159	CcSEcCtD
Abacavir—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00831	0.0147	CcSEcCtD
Abacavir—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00803	0.0142	CcSEcCtD
Abacavir—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00728	0.0129	CcSEcCtD
Abacavir—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.0124	CcSEcCtD
Abacavir—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.0122	CcSEcCtD
Abacavir—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00633	0.0112	CcSEcCtD
Abacavir—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.0108	CcSEcCtD
Abacavir—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00582	0.0103	CcSEcCtD
Abacavir—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00567	0.01	CcSEcCtD
Abacavir—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.0097	CcSEcCtD
Abacavir—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00548	0.00967	CcSEcCtD
Abacavir—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00526	0.00929	CcSEcCtD
Abacavir—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.00911	CcSEcCtD
Abacavir—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00909	CcSEcCtD
Abacavir—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00855	CcSEcCtD
Abacavir—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00481	0.0085	CcSEcCtD
Abacavir—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00843	CcSEcCtD
Abacavir—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.00833	CcSEcCtD
Abacavir—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.00831	CcSEcCtD
Abacavir—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00828	CcSEcCtD
Abacavir—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00828	CcSEcCtD
Abacavir—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.00824	CcSEcCtD
Abacavir—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.00821	CcSEcCtD
Abacavir—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.00799	CcSEcCtD
Abacavir—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00759	CcSEcCtD
Abacavir—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00753	CcSEcCtD
Abacavir—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.00745	CcSEcCtD
Abacavir—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00681	CcSEcCtD
Abacavir—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.0067	CcSEcCtD
Abacavir—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.0066	CcSEcCtD
Abacavir—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00613	CcSEcCtD
Abacavir—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.0061	CcSEcCtD
Abacavir—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00595	CcSEcCtD
Abacavir—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00593	CcSEcCtD
Abacavir—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.00591	CcSEcCtD
Abacavir—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00326	0.00576	CcSEcCtD
Abacavir—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00572	CcSEcCtD
Abacavir—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.00562	CcSEcCtD
Abacavir—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.00562	CcSEcCtD
Abacavir—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.0056	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.00558	CcSEcCtD
Abacavir—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00555	CcSEcCtD
Abacavir—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.00539	CcSEcCtD
Abacavir—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.00539	CcSEcCtD
Abacavir—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.00535	CcSEcCtD
Abacavir—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00529	CcSEcCtD
Abacavir—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00528	CcSEcCtD
Abacavir—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00523	CcSEcCtD
Abacavir—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00514	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00491	CcSEcCtD
Abacavir—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00487	CcSEcCtD
Abacavir—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00484	CcSEcCtD
Abacavir—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.0048	CcSEcCtD
Abacavir—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00468	CcSEcCtD
Abacavir—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00465	CcSEcCtD
Abacavir—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00465	CcSEcCtD
Abacavir—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00461	CcSEcCtD
Abacavir—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00444	CcSEcCtD
Abacavir—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00441	CcSEcCtD
Abacavir—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00428	CcSEcCtD
Abacavir—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00426	CcSEcCtD
Abacavir—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00426	CcSEcCtD
Abacavir—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00397	CcSEcCtD
Abacavir—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00387	CcSEcCtD
Abacavir—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00381	CcSEcCtD
Abacavir—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00369	CcSEcCtD
Abacavir—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00356	CcSEcCtD
Abacavir—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00343	CcSEcCtD
Abacavir—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.0034	CcSEcCtD
Abacavir—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00339	CcSEcCtD
Abacavir—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00338	CcSEcCtD
Abacavir—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0032	CcSEcCtD
